August 12, 2013

Antigen and transforming growth factor beta receptors contribute to long term functional and phenotypic heterogeneity of memory CD8 T cells

Front. Immunol., 12 August 2013 | doi: 10.3389/fimmu.2013.00227

Antigen and transforming growth factor beta receptors contribute to long term functional and phenotypic heterogeneity of memory CD8 T cells

Yinghong Hu and Linda Cauley*
  • University of Connecticut Health Center, Farmington, CT, USA
Pathogen-specific CD8 T cells provide a mechanism for selectively eliminating host cells that are harboring intracellular pathogens. The pathogens are killed when lytic molecules are injected into the cytoplasm of the infected cells and begin an apoptotic cascade. Activated CD8 T cells also release large quantities of pro-inflammatory cytokines that stimulate other immune cells in the local vicinity. As the alveoli are extraordinarily sensitive to cytokine induced damage, multiple layers of immune regulation limit the activities of immune cells that enter the lungs. These mechanisms include receptor-mediated signaling pathways in CD8 T cells that respond to peptide antigens and transforming growth factor β. Both pathways influence the functional and phenotypic properties of long-lived CD8 T cells populations in peripheral and lymphoid tissues.












Keywords: transforming growth factor beta, CD8 T cells, homing receptors, prolonged antigen presentation, tissue-resident memory cells, migration
Citation: Hu Y and Cauley L (2013) Antigen and transforming growth factor beta receptors contribute to long term functional and phenotypic heterogeneity of memory CD8 T cells.Front. Immunol. 4:227. doi: 10.3389/fimmu.2013.00227
Received: 07 April 2013; Accepted: 18 July 2013;
Published online: 12 August 2013.
Edited by:
Susan Swain, University of Massachusetts Medical School, USA
Reviewed by:
David Hildeman, Cincinnati Children’s Hospital, USA
Shahram Salek-Ardakani, University of Florida, USA
Copyright: © 2013 Hu and Cauley. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Linda Cauley, University of Connecticut Health Center, 263 Farmington Avenue, MC1319 Farmington, CT 06032, USA e-mail: lcauley@uchc.edu


Myofibroblast expression in airways and alveoli is affected by smoking and COPD

Open Access
Research

Myofibroblast expression in airways and alveoli is affected by smoking and COPD

Henna M KarvonenSiri T LehtonenTerttu HarjuRaija T SormunenElisa Lappi-Blanco,Johanna M MäkinenKirsi LaitakariShirley Johnson and Riitta L Kaarteenaho
For all author emails, please log on.
Respiratory Research 2013, 14:84 doi:10.1186/1465-9921-14-84
Published: 11 August 2013

Abstract (provisional)

Background

Chronic obstructive pulmonary disease (COPD) is characterized by structural changes in alveoli and airways. Our aim was to analyse the numbers of alpha-smooth muscle actin (alpha-SMA) positive cells, as a marker of myofibroblasts, in different lung compartments in non-smokers and smokers with normal lung function or COPD.

Methods

alpha-SMA, tenascin-C (Tn-C) and EDA-fibronectin in alveolar level and airways were assayed by immunohistochemistry and quantified by image analysis. Immunohistochemical findings were correlated with clinical data. alpha-SMA protein was also analysed by Western blotting from fibroblastic cells cultured from peripheral lung of non-smokers, smokers without COPD and smokers with COPD.

Results

In many cases, the endings of the detached alveolar walls were widened, the structures of which were named as widened alveolar tips. Widened alveolar tips contained alpha-SMA positive cells, which were obviously myofibroblasts. There were less alveolar tips containing positive cells for alpha-SMA in alveoli and alpha-SMA positive cells in bronchioles in smokers and in COPD compared to non-smokers. The quantity of alpha-SMA positive cells was increased in bronchi in COPD. Tn-C was elevated in bronchi in COPD and smokers' lung. The alpha-SMA protein level was 1.43-fold higher in stromal cells cultured from non-smokers than in those of smokers.

Conclusions

Myofibroblasts are localized variably in normal and diseased lung. This indicates that they have roles in both regeneration of lung and pathogenesis of COPD. The widened alveolar tips, these newly characterized histological structures, seemed to be the source of myofibroblasts at the alveolar level.

The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.

Role of leukotrienes in exercise-induced bronchoconstriction before and after a pilot rehabilitation training program

Role of leukotrienes in exercise-induced bronchoconstriction before and after a pilot rehabilitation training program



Original Research

(273) Total Article Views


Authors: El-Akkary IM, El-Khouly ZA, El-Seweify ME, El-Batouti GA, Abdel Aziz E, Adam AI

Published Date July 2013 Volume 2013:6 Pages 631 - 636
DOI: http://dx.doi.org/10.2147/IJGM.S46953

Ibrahim M El-Akkary,1 Zeinat Abdel-Fatah El-Khouly,2 Mervat El-Sayed El-Seweify,1 Gihan A El-Batouti,3 Ekhlas Abdel Aziz,2 Abdelnasser I Adam1
1Department of Human Physiology, 2Department of Applied Medical Chemistry, Medical Research Institute, Alexandria University, 3Department of Microbiology and Immunology, Faculty of Pharmacy, Pharos University, Alexandria, Egypt

Background: Whatever the initial stimulus for the exercise-induced bronchoconstriction (EIB) observed in asthmatic patients after exercise, the final effect is release of bronchoactive mediators, especially cysteinyl leukotrienes. Exercise rehabilitation training programs have been reported to protect against EIB. The exact mechanism(s) involved are not well understood. However, this protective effect may be related to adaptation and better coordination during exercise, depletion of cysteinyl leukotrienes, and/or a sluggish cysteinyl leukotriene response to exercise. The aim of the present work was to test the hypothesis that improvement in the incidence and severity of post-exercise bronchoconstriction after a rehabilitation training program is related to a change in leukotriene levels in response to exercise.
Methods: Twenty asthmatic children aged 6–12 years and known to develop EIB were enrolled in an exercise training program for 12 weeks. The severity and incidence of EIB before and after training was assessed. Baseline and post-exercise sputum cysteinyl leukotriene levels were assessed before and after the training program.
Results: The training program offered significant protection against EIB with a concomitant decrease in sputum cysteinyl leukotriene levels in response to exercise.
Conclusion: A training program can result in depletion and/or a sluggish cysteinyl leukotriene response to exercise and may be responsible for the protective effect of training programs on EIB. It is recommended to use an exercise rehabilitation training program as a complementary tool in the management of bronchial asthma, especially EIB.

Keywords: asthma, leukotrienes, exercise-induced bronchoconstriction, sputum, cysteinyl leukotriene, rehabilitation training program




Post to:
CannoteaCiteulikeDel.icio.usFacebookLinkedInTwitter

August 10, 2013

Association between Interleukin-4 Receptor α Chain (IL4RA) I50V and Q551R Polymorphisms and Asthma Risk

RESEARCH ARTICLE

Association between Interleukin-4 Receptor α Chain (IL4RA) I50V and Q551R Polymorphisms and Asthma Risk: An Update Meta-Analysis

  • Wei Nie equal contributor,
  •  
  • Yuansheng Zang equal contributor,
  •  
  • Jiquan Chen equal contributor,
  •  
  • Qingyu Xiu mail
  • Abstract

    Background


    The associations between the interleukin-4 receptor α chain (IL4RA) I50V and Q551R polymorphisms and asthma risk remained controversial.

    Methods


    We searched the Pubmed, Embase, Chinese National Knowledge Infrastructure (CNKI) and Wanfang databases for studies published before February 2013. The strengths of the associations were calculated using odds ratios (ORs) with 95% confidence intervals (CIs).

    Results


    A total of 50 studies were included in this meta-analysis. There was a significant association between the IL4RA I50V polymorphism and asthma risk in a dominant genetic model (OR = 1.13, 95% CI 1.04–1.23, P = 0.005). The IL4RA Q551R polymorphism was associated with a significantly elevated asthma risk in a recessive genetic model (OR = 1.46, 95% CI 1.22–1.75,P-0.0001). Subgroup analyses found that the IL4RA I50V polymorphism was significantly associated with asthma risk in Asians (OR = 1.72, 95% CI 1.31–2.25, P-0.0001), pediatric asthma risk (OR = 1.50, 95% CI 1.13–1.99, P = 0.005), and atopic asthma risk (OR = 1.88, 95% CI 1.27–2.79, P = 0.002).

    Conclusions


    The results of this meta-analysis suggested that the IL4RA I50V and Q551R polymorphisms may be risk factors for developing asthma.

    Association between the polymorphisms of interleukin-4, the interleukin-4 receptor gene and asthma


    Chinese Medical Journal 2013;126(15):2943-2951
    Association between the polymorphisms of interleukin-4, the interleukin-4 receptor gene and asthma

    ZHU Ning, GONG Yi, CHEN Xiao-dong, ZHANG Jing, LONG Feng, HE Jian, XIA Jing-wen and DONG Liang
    Keywords
    interleukin-4; interleukin-4 receptor; asthma; gene polymorphism; case-controlled study; meta-analysis
    Abstract
    Background Interleukin-4 (IL4) is one of the most important cytokines involved in a variety of 
    allergic disorders, particularly, asthma. A number of genetic epidemiological studies have identified 
    an association between the gene polymorphisms of IL4 and interleukin-4 receptor (IL4R) and asthma 
    in different populations. However, these studies have been inconsistent and inconclusive. The aim of this 
    study was to investigate the association between the single nucleotide polymorphism (SNP) of IL-4, 
    IL-4R and asthma risk in case-controlled studies using meta-analysis.
    Method A genetic model-free approach was used to perform the meta-analysis. Asthma (atopy status 
    nondefined), nonatopic and atopic asthma subgroups were separately analyzed. Next, the ethnic 
    subgroup was analyzed. Heterogeneity and publication bias were also explored.
    Results Only two polymorphisms of IL4 (rs2243250 and rs2070874) and four polymorphisms of 
    IL4R (rs1801275, rs1805011, rs1805010, and rs1805015) were included in the meta-analysis. 
    Polymorphisms rs2243250 and rs2070874 of IL-4 and rs1801275 and rs1805011 of IL4R were associated 
    with asthma. The overall odds ratio (OR) of rs2243250 in the CC versus TT+TC genotypes was 0.84 
    (95% CI: 0.75–0.94), and the Z-test for the overall effect was 3.0 (P=0.003). We obtained significant 
    results from this polymorphism in the Caucasian ethnicity and adult groups. However, the overall OR of 
    rs1801275 for the GG+AG versus AA genotype was 1.16 (95% CI: 1.00–1.35), and the Z-test for the 
    overall effect was 1.87 (P=0.06). Moreover, significant results were only obtained from the sub-group 
    analysis in Asians (P=0.02). In the rs1805011 polymorphism of IL4R, the overall OR for the CC +AC versus 
    AA genotypes was 0.39 (95% CI: 0.16–0.95), and the Z-test for the overall effect was 2.08 (P=0.04).
    Conclusions
    Both the IL4 and IL4R polymorphisms were associated with asthma. The rs2243250 polymorphism of IL4 
    was more important in the white and adult groups. Individuals who carried the C allele for rs2070874 of the 
    IL4 gene demonstrated increased asthma risk compared to TT homozygotes. An individual with an AA 
    genotype in rs1805011 of the IL4R gene was less likely to suffer from asthma compared to the other two 
    genotypes.

    General practice variation in spirometry testing among patients receiving first-time prescriptions for medication targeting obstructive lung disease

    Open Access
    Research article

    General practice variation in spirometry testing among patients receiving first-time prescriptions for medication targeting obstructive lung disease in Denmark: a population-based observational study

    Mette M KoefoedJens SøndergaardRené dePont Christensen and Dorte E Jarbøl
    For all author emails, please log on.
    BMC Family Practice 2013, 14:113 doi:10.1186/1471-2296-14-113
    Published: 7 August 2013

    Abstract (provisional)

    Background

    Spirometry testing is essential to confirm an obstructive lung disease, but studies have reported that a large proportion of patients diagnosed with COPD or asthma have no history of spirometry testing. Also, it has been shown that many patients are prescribed medication for obstructive lung disease without a relevant diagnosis or spirometry test registered. General practice characteristics have been reported to influence diagnosis and management of several chronic diseases. However, these findings are inconsistent, and it is uncertain whether practice characteristics influence spirometry testing among patients receiving medication for obstructive lung disease. The aim of this study was therefore to examine if practice characteristics are associated with spirometry testing among patients receiving first-time prescriptions for medication targeting obstructive lung disease.

    Methods

    A national register-based cohort study was performed. All patients over 18 years receiving first-time prescriptions for medication targeting obstructive lung disease in 2008 were identified and detailed patient-specific data on sociodemographic status and spirometry tests were extracted. Information on practice characteristics like number of doctors, number of patients per doctor, training practice status, as well as age and gender of the general practitioners was linked to each medication user.

    Results

    Partnership practices had a higher odds ratio (OR) of performing spirometry compared with single-handed practices (OR 1.24, CI 1.09-1.40). We found a significant association between increasing general practitioner age and decreasing spirometry testing. This tendency was most pronounced among partnership practices, where doctors over 65 years had the lowest odds of spirometry testing (OR 0.25, CI 0.10-0.61). Training practice status was significantly associated with spirometry testing among single-handed practices (OR 1.40, CI 1.10-1.79).

    Conclusion

    Some of the variation in spirometry testing among patients receiving first-time prescriptions for medication targeting obstructive lung disease was associated with practice characteristics. This variation in performance may indicate a potential for quality improvement.

    The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.

    GST-omega genes interact with environmental tobacco smoke on adult level of lung function

    Open Access
    Research

    GST-omega genes interact with environmental tobacco smoke on adult level of lung function

    Kim de JongH Marike BoezenNick HT HackenDirkje S Postma and Judith M Vonk
    For all author emails, please log on.
    Respiratory Research 2013, 14:83 doi:10.1186/1465-9921-14-83
    Published: 9 August 2013

    Abstract (provisional)

    Background

    Lung growth in utero and lung function loss during adulthood can be affected by exposure to environmental tobacco smoke (ETS). The underlying mechanisms have not been fully elucidated. Both ETS exposure and single nucleotide polymorphisms (SNPs) in Glutathione S-Transferase (GST) Omega genes have been associated with the level of lung function. This study aimed to assess if GSTO SNPs interact with ETS exposure in utero and during adulthood on the level of lung function during adulthood.

    Methods

    We used cross-sectional data of 8,128 genotyped participants from the LifeLines cohort study. Linear regression models (adjusted for age, sex, height, weight, current smoking, ex-smoking and packyears smoked) were used to analyze the associations between in utero, daily and workplace ETS exposure, GSTO SNPs, the interaction between ETS and GSTOs, and level of lung function (FEV1, FEV1/FVC). Since the interactions between ETS and GSTOs may be modified by active tobacco smoking we additionally assessed associations in never and ever smokers separately. A second sample of 5,308 genotyped LifeLines participants was used to verify our initial findings.

    Results

    Daily and workplace ETS exposure was associated with significantly lower FEV1 levels. GSTO SNPs (recessive model) interacted with in utero ETS and were associated with higher levels of FEV1, whereas the interactions with daily and workplace ETS exposure were associated with lower levels of FEV1, effects being more pronounced in never smokers. The interaction of GSTO2 SNP rs156697 with in utero ETS associated with a higher level of FEV1 was significantly replicated in the second sample. Overall, the directions of the interactions of in utero and workplace ETS exposure with the SNPs found in the second (verification) sample were in line with the first sample.

    Conclusions

    GSTO genotypes interact with in utero and adulthood ETS exposure on adult lung function level, but in opposite directions.

    The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.